Showing results (1-10 of 64) with videos related to
Sort By:
Pageof 7
Endocrine, Metabolic & Immune Disorders Drug Targets|September 11, 2008
Cannabinoids as therapeutic agents for ablating neuroinflammatory diseaseG A Cabral, L Griffin-ThomasProceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|February 1, 1992
delta 9-Tetrahydrocannabinol suppresses macrophage extrinsic antiherpesvirus activityG A Cabral, R VasquezJournal of Toxicology and Environmental Health|January 1, 1989
Delta-9-tetrahydrocannabinol inhibits macrophage protein expression in response to bacterial immunomodulatorsG A Cabral, E M MishkinJournal of Virology|May 1, 1976
Electron microscope studies of temperature-sensitive mutants of herpes simplex virus type 2G A Cabral, P A SchafferJournal of Leukocyte Biology|October 6, 2005
Cannabinoid receptors in microglia of the central nervous system: immune functional relevanceG A Cabral, F Marciano-CabralLife Sciences|January 1, 1994
Inhibition of macrophage inducible protein expression by delta-9-tetrahydrocannabinolG A Cabral, K Fischer-StengerProceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|October 1, 1995
Differential inhibition of RAW264.7 macrophage tumoricidal activity by delta 9tetrahydrocannabinolD Burnette-Curley, G A CabralProceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|May 1, 1987
Inhibition of cell-associated herpes simplex virus type 2 glycoproteins by delta 9-tetrahydrocannabinolE M Mishkin, G A CabralThe Journal of General Virology|December 1, 1985
delta-9-Tetrahydrocannabinol decreases host resistance to herpes simplex virus type 2 vaginal infection in the B6C3F1 mouseE M Mishkin, G A CabralPageof 7